Tech Company Financing Transactions
ViewRay Funding Round
ViewRay closed a $20 million Series C funding round on 8/25/2010. Investors included Siemens Venture Capital, Aisling Capital and F-Prime Capital.
Transaction Overview
Company Name
Announced On
8/25/2010
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series C
Investors
Siemens Venture Capital (Lead Investor) (Ralf Schnell)
Proceeds Purpose
The funding is intended to move the ViewRay system, a unique image-guided radiation therapy system now in the late stages of development, through the process of commercialization and placement in major medical centers.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
2 Thermo Fisher Way
Oakwood Village, OH 44146
USA
Oakwood Village, OH 44146
USA
Phone
Website
Email Address
Overview
ViewRay (OTC: VRAY) sells a patent pending Renaissance race System 1000 that combines two proven technologies: magnetic resonance imaging (MRI) and gamma ray radiotherapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Drake
Chief Financial Officer
Ajay Bansal
Chief Medical Officer
Martin Fuss
Chief Operating Officer
Shar Matin
Chief Scientific Officer
James Dempsey
VP - General Counsel
Robert McCormack
VP - Human Resources
Robert Fuchs
Browse more venture capital transactions:
Prev: 8/25/2010: Healthsense venture capital transaction
Next: 8/25/2010: Tillster venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs